|
1
|
Rosai J and Dorfman RF: Sinus
histiocytosis with massive lymphadenopathy. A newly recognized
benign clinicopathological entity. Arch Pathol. 87:63–70.
1969.PubMed/NCBI
|
|
2
|
Foucar E, Rosai J and Dorfman R: Sinus
histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease):
Review of the entity. Semin Diagn Pathol. 7:19–73. 1990.PubMed/NCBI
|
|
3
|
Chappell JA, Burkemper NM, Frater JL and
Hurley MY: Cutaneous rosai-dorfman disease and morphea: Coincidence
or association? Am J Dermatopathol. 31:487–489. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brenn T, Calonje E, Granter SR, Leonard N,
Grayson W, Fletcher CD and McKee PH: Cutaneous rosai-dorfman
disease is a distinct clinical entity. Am J Dermatopathol.
24:385–391. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pulsoni A, Anghel G, Falcucci P, Matera R,
Pescarmona E, Ribersani M, Villivà N and Mandelli F: Treatment of
sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman
disease): Report of a case and literature review. Am J Hematol.
69:67–71. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Elbuluk N, Egbers R, Taube JM and Wang TS:
Cutaneous Rosai-Dorfman Disease in a Patient with Human
Immunodeficiency Virus. Dermatol Online J.
22:13030/qt2162h3fj2016.PubMed/NCBI
|
|
7
|
Chen J, Tang H, Li B and Xiu Q:
Rosai-Dorfman disease of multiple organs, including the epicardium:
An unusual case with poor prognosis. Heart Lung. 40:168–171. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ottaviano G, Doro D, Marioni G, Mirabelli
P, Marchese-Ragona R, Tognon S, Marino F and Staffieri A:
Extranodal Rosai-Dorfman disease: Involvement of eye, nose and
trachea. Acta Otolaryngol. 126:657–660. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dalia S, Sagatys E, Sokol L and Kubal T:
Rosai-Dorfman Disease: Tumor Biology, Clinical Features, Pathology,
and Treatment Cancer Control. October;2014.21(4)
|
|
10
|
McClain KL, Natkunam Y and Swerdlow SH:
Atypical cellular disorders. Hematology (Am Soc Hematol Educ
Program). 2004:283–296. 2004.
|
|
11
|
La Barge DV III, Salzman KL, Harnsberger
HR, Ginsberg LE, Hamilton BE, Wiggins RH III and Hudgins PA: Sinus
histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease):
Imaging manifestations in the head and neck. AJR Am J Roentgenol.
191:W299–306. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zaveri J, La Q, Yarmish G and Neuman J:
More than just Langerhans cell histiocytosis: A radiologic review
of histiocytic disorders. Radiographics. 34:2008–2024. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu JQ, Zhuang H, Xiu Y, Talati E and Alavi
A: Demonstration of increased FDG activity in Rosai-Dorfman disease
on positron emission tomography. Clin Nucl Med. 29:209–210. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mosheimer BA, Oppl B, Zandieh S, Fillitz
M, Keil F, Klaushofer K, Weiss G and Zwerina J: Bone Involvement in
Rosai-Dorfman Disease (RDD): A Case Report and Systematic
Literature Review. Curr Rheumatol Rep. 19:292017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thawerani H, Sanchez RL, Rosai J and
Dorfman RF: The cutaneous manifestations of sinus histiocytosis
with massive lymphadenopathy. Arch Dermatol. 114:191–197. 1978.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang KH, Chen WY, Liu HN, Huang CC, Lee WR
and Hu CH: Cutaneous Rosai-Dorfman disease: Clinicopathological
profiles, spectrum and evolution of 21 lesions in six patients. Br
J Dermatol. 154:277–286. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cole S and Finlay J:
2-Chlorodeoxyadenosine for adults with multi-system Langerhans cell
histiocytosis. Med Pediatr Oncol. 33:5121999.
|
|
18
|
Rubenstein MA, Farnsworth NN, Pielop JA,
Orengo IF, Curry JL, Drucker CR and Hsu S: Cutaneous Rosai-Dorfman
disease. Dermatol Online J. 12:82006.PubMed/NCBI
|
|
19
|
Hervier B, Haroche J, Arnaud L, Charlotte
F, Donadieu J, Néel A, Lifermann F, Villabona C, Graffin B, Hermine
O, et al French Histiocytoses Study Group, : Association of both
Langerhans cell histiocytosis and Erdheim-Chester disease linked to
the BRAFV600E mutation. Blood. 124:1119–1126. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Weitzman S and Jaffe R: Uncommon
histiocytic disorders: The non-Langerhans cell histiocytoses.
Pediatr Blood Cancer. 45:256–264. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Emile JF, Abla O, Fraitag S, Horne A,
Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab
O, Allen CE, et al Histiocyte Society, : Revised classification of
histiocytoses and neoplasms of the macrophage-dendritic cell
lineages. Blood. 127:2672–2681. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
O'Malley DP, Duong A, Barry TS, Chen S,
Hibbard MK, Ferry JA, Hasserjian RP, Thompson MA, Richardson MS,
Jaffe R, et al: Co-occurrence of Langerhans cell histiocytosis and
Rosai-Dorfman disease: Possible relationship of two histiocytic
disorders in rare cases. Mod Pathol. 23:1616–1623. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Juskevicius R and Finley JL: Rosai-Dorfman
disease of the parotid gland: Cytologic and histopathologic
findings with immunohistochemical correlation. Arch Pathol Lab Med.
125:1348–1350. 2001.PubMed/NCBI
|
|
24
|
Kong YY, Kong JC, Shi DR, Lu HF, Zhu XZ,
Wang J and Chen ZW: Cutaneous rosai-dorfman disease: A clinical and
histopathologic study of 25 cases in China. Am J Surg Pathol.
31:341–350. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bonetti F, Chilosi M, Menestrina F, Scarpa
A, Pelicci PG, Amorosi E, Fiore-Donati L and Knowles DM II:
Immunohistological analysis of Rosai-Dorfman histiocytosis. A
disease of S-100 + CD1-histiocytes. Virchows Arch A Pathol Anat
Histopathol. 411:129–135. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ying M, Ahuja AT and Yuen HY: Grey-scale
and power Doppler sonography of unusual cervical lymphadenopathy.
Ultrasound Med Biol. 30:449–454. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Karunanithi S, Singh H, Sharma P, Naswa N
and Kumar R: 18F-FDG PET/CT imaging features of Rosai Dorfman
disease: A rare cause of massive generalized lymphadenopathy. Clin
Nucl Med. 39:268–269. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tsang JS, Anthony MP, Wong MP and Wong CS:
The use of FDG-PET/CT in extranodal Rosai-Dorfman disease of bone.
Skeletal Radiol. 41:715–717. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Albano D, Bosio G and Bertagna F: 18F-FDG
PET/CT follow-up of Rosai-Dorfman disease. Clin Nucl Med.
40:e420–e422. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ha H, Kim KH, Ahn YJ, Kim JH, Kim JE and
Yoon S-S: A rare case of Rosai-Dorfman disease without
lymphadenopathy. Korean J Intern Med. 31:802–804. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shaikh F, Awan O, Mohiuddin S, Farooqui S,
Khan SA and McCartney W: 18F-FDG PET/CT Imaging of Extranodal
Rosai-Dorfman Disease with Hepatopancreatic Involvement - A
Pictorial and Literature Review. Cureus. 7:e3922015.PubMed/NCBI
|
|
32
|
Liu B, Lee NJ, Otero HJ, Servaes S and
Zhuang H: Rosai-Dorfman disease mimics lymphoma on FDG PET/CT in a
pediatric patient. Clin Nucl Med. 39:206–208. 2014.PubMed/NCBI
|
|
33
|
Deshayes E, Le Berre JP, Jouanneau E,
Vasiljevic A, Raverot G and Seve P: 18F-FDG PET/CT findings in a
patient with isolated intracranial Rosai-Dorfman disease. Clin Nucl
Med. 38:e50–e52. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Le Guenno G, Galicier L, Uro-Coste E,
Petitcolin V, Rieu V and Ruivard M: Successful treatment with
azathioprine of relapsing Rosai-Dorfman disease of the central
nervous system. J Neurosurg. 117:486–489. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang JY, Lu CC, Hsiao CH and Tzen KY: FDG
PET/CT findings in purely cutaneous Rosai-Dorfman disease. Clin
Nucl Med. 36:e13–e15. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Madhunapantula SV, Gowda R, Inamdar GS and
Robertson GP: In situ photoimmunotherapy: A new hope for cutaneous
melanoma patients. Cancer Biol Ther. 10:1088–1090. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Adeleye AO, Amir G, Fraifeld S, Shoshan Y,
Umansky F and Spektor S: Diagnosis and management of Rosai-Dorfman
disease involving the central nervous system. Neurol Res.
32:572–578. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li M, Shi L, Luo M, Chen J, Wang B, Zhang
F, Keyal U, Bhatta AK, Chen WR and Wang X: Successful treatment of
Rosai-Dorfman disease using in situ photoimmunotherapy. Indian J
Dermatol Venereol Leprol. 83:332–336. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lu LY, Ju WT, Cai M and Lu XF: Cutaneous
Rosai-Dorfman disease recurrence in infraorbital region. J
Craniofac Surg. 23:e509–e510. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dalia S, Sagatys E, Sokol L and Kubal T:
Rosai-Dorfman disease: Tumor biology, clinical features, pathology,
and treatment. Cancer Control. 21:322–327. 2014. View Article : Google Scholar : PubMed/NCBI
|
